AmbioPharm
AmbioPharm provides peptide API process development, scale-up, GMP manufacturing, and HPLC or UPLC method development and validation.
At a glance
Delivery model
Main areasCapabilities
AmbioPharm is a CDMO and laboratory services provider focused on peptide APIs. Its services span process development, scale-up, GMP manufacturing, and analytical method development and validation for products from preclinical development through commercialization.
What It Helps Teams Do
- Develop and scale peptide API processes from preclinical work through commercialization, including GMP manufacturing for clinical and commercial products.
- Manufacture peptide APIs at gram to multi-kilogram scale using solid-phase and solution processes in FDA-inspected manufacturing suites.
- Develop and validate HPLC or UPLC methods to separate related substances and degradants, with method-development and validation reports for clients.
- Assist with IND (Investigational New Drug) filings for client programs.
Best Fit
- Best suited to pharmaceutical teams seeking a peptide-focused CDMO for process development, scale-up, GMP API manufacturing, and supporting analytical method work.
Reviewed capability coverage
Backed by 5 pages from the vendor's own site. Select a capability to see its quote and source.
Manufacturing & Supply Chain3 capabilities
Integrated CDMO, Development & Technology Transfer
Small-Molecule API & Advanced Modality Manufacturing
Formulation, Analytical, QC & Stability
Regulatory, Quality & Safety1 capability
Clinical & Marketing Applications
Work at AmbioPharm? Claim this free profile to correct details and see how buyers find you.
Claim profileSimilar vendors
